To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Biotechnology 22, 177–183 (1 February 2004) | doi:10.1038/nbt926
Henning Hermjakob , Luisa Montecchi-Palazzi , Gary Bader , J|[eacute]|r|[ocirc]|me Wojcik , Lukasz Salwinski , Arnaud Ceol , Susan Moore , Sandra Orchard , Ugis Sarkans , Christian von Mering , Bernd Roechert , Sylvain Poux , Eva Jung , Henning Mersch , Paul Kersey , Michael Lappe , Yixue Li , Rong Zeng , Debashis Rana , Macha Nikolski , Holger Husi , Christine Brun , K Shanker , Seth G N Grant , Chris Sander , Peer Bork , Weimin Zhu , Akhilesh Pandey , Alvis Brazma , Bernard Jacq , Marc Vidal , David Sherman , Pierre Legrain , Gianni Cesareni , Ioannis Xenarios , David Eisenberg , Boris Steipe , Chris Hogue & Rolf Apweiler
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Personal subscribers to Nature Biotechnology can view articles published from 1997 to the current issue. To do this, associate your subscription with your registration via the My Account page. If you already have an active subscription, login here to your nature.com account.
If you do not have access to the article you require, you can purchase the article (see below) or access it through a site license. A site license includes a minimum of four years of archived content; institutions can add additional archived content to their license at any time. Recommend site license access to your institution.
Price: US$32
In order to purchase this article you must be a registered user.
You can also request this document from your local library through inter library loan services.
